Medical Physicist Ph.D. at Izmir City Hospital, Turkey.
Dr. Burรงin Hazeral ๐ is a dedicated medical physicist from Turkey ๐น๐ท with over 15 years of experience in radiation oncology. She currently serves at ฤฐzmir City Hospital ๐ฅ, where she integrates advanced physics into cancer care. A lifelong learner and researcher, Dr. Hazeral has made notable contributions in adaptive radiotherapy, in vivo dosimetry, and cancer treatment planning ๐ฌ๐. Her work bridges clinical application and academic excellence, with several publications in globally recognized SCI and Scopus-indexed journals ๐๐. Known for her collaborative nature, she works closely with leading oncology centers and contributes to medical advancement through research, innovation, and professional society involvement ๐ค๐ก. Passionate about patient-centered radiation therapy, she brings precision and compassion to every case. With a strong ethical foundation and scientific rigor, Dr. Hazeral continues to shape the future of medical physics and cancer treatment technology ๐๐ง .
Professional Profile
Scopus
ORCID
Google Scholar
Suitability For Best Researcher Award – Dr. Burcin Hazeral
Dr. Burรงin Hazeral is an exceptional candidate for the Best Researcher Award due to her outstanding contributions to the field of clinical medical physics, particularly in radiation oncology. With over 15 years of hands-on experience, she has effectively merged clinical expertise with innovative research to improve cancer treatment outcomes. Her research focuses on adaptive radiotherapy, in vivo dosimetry, and dosimetric safety for critical organs, which are central to enhancing precision, safety, and personalization in cancer therapy.
Educationย
Dr. Burรงin Hazeralโs academic journey began with a Bachelorโs degree in Physics from Ege University in 2006 ๐. She pursued her passion for healthcare by earning a Master of Science in Medical Physics in 2010. Her dedication to continuous learning led her to complete her Ph.D. in Medical Physics in 2024 from the same institution, focusing on innovative radiotherapy techniques. This solid academic foundation empowers her to merge theoretical physics with real-world applications in oncology ๐ฅ๐.
Professional Developmentย
With a professional journey spanning over 15 years, Dr. Burรงin Hazeral has established herself as a leader in the field of medical physics. Working in top-tier oncology centers such as ฤฐzmir Onkomer, Ege Oncology, and currently ฤฐzmir City Hospital ๐ฅ, she has contributed to clinical excellence in cancer care. Her work involves advanced treatment planning, quality assurance, and integration of imaging and dosimetry into therapy workflows ๐๐ป. Dr. Hazeral frequently collaborates with interdisciplinary teams and participates in national societies like the Turkish Society for Medical Physics and the Turkish Society for Radiation Oncology. She regularly presents her work at professional congresses and contributes to peer-reviewed journals, playing a pivotal role in enhancing clinical radiotherapy standards. Committed to safety, precision, and patient-centered care, her career reflects a continuous drive toward innovation, learning, and impactful research ๐.
Research Focus Areaย
Dr. Hazeralโs primary research focus lies in radiation oncology and medical physics, especially in the enhancement of radiotherapy precision through adaptive methods. She specializes in adaptive radiotherapy techniques for head and neck cancers, in vivo dosimetry, and dosimetric analysis for breast, glottic, and brain tumors. Her recent work has explored hippocampal sparing in glioma patients and dose exposure comparisons using simulation-based planning ๐ฅ๏ธ๐. This research contributes to optimizing radiation dose delivery, minimizing exposure to healthy tissues, and improving patient outcomes ๐๐ก. Her studies integrate imaging, planning software, and real-time feedback, aligning with personalized medicine strategies. By focusing on cancers with complex anatomical and dose delivery challenges, her work bridges innovation with practical clinical improvements. Through her projects, Dr. Hazeral contributes to safer and more effective treatment solutions in the fight against cancer ๐.
Research Skills Categoryย
Dr. Burรงin Hazeral brings a diverse set of advanced research skills rooted in medical physics and radiotherapy innovation ๐ฌโ๏ธ. She excels in treatment planning systems (TPS), dosimetric modeling, radiation dose measurements, and comparative radiotherapy studies. Her strengths include in vivo dosimetry techniques, real-time dose verification, adaptive planning, and simulation-based methodology development ๐ก๐. She is proficient in using IMRT (Intensity-Modulated Radiation Therapy) and VMAT (Volumetric Modulated Arc Therapy) systems, particularly in complex cancer scenarios such as head & neck and breast cancers ๐ฏ. Dr. Hazeral is also skilled in statistical data analysis, scientific writing, and interdisciplinary collaborationโenabling robust and clinically relevant research outcomes. Her work frequently combines imaging techniques with radiation science, embodying a skill set that is both technically deep and clinically applicable. These competencies make her a valuable contributor to research, innovation, and evidence-based radiotherapy practices ๐๐ป.
Awards and Honorsย
While formal award listings are not explicitly provided, Dr. Burรงin Hazeralโs scientific contributions and clinical impact speak volumes ๐ฃ๏ธ๐. Her published works in top-tier journals such as SpringerPlus, Journal of Cancer Research and Therapeutics, and Medical Dosimetry underscore her recognition in the medical physics community ๐๐. Her article on hippocampal dose distribution in gliomas has received significant citations, highlighting her scholarly impact ๐๐ก. As a frequent presenter at national congresses, particularly under the Turkish Society for Radiation Oncology, she is a respected voice in her field ๐น๐ท๐๏ธ. Her involvement in collaborative projects across major oncology centers has also positioned her as a thought leader in clinical research ๐ค๐ฅ. As her career evolves, she remains a strong candidate for national and international recognition in clinical radiotherapy innovation and patient safety in cancer care ๐๐๏ธ.
Publication Top Notesย
1. Comparison of dose distributions hippocampus in high grade gliomas irradiation with linac-based IMRT and volumetric arc therapy: a dosimetric study
๐ Citation Count: 30
๐
Year: 2015
๐ Journal: SpringerPlus
๐ฉโโ๏ธ Authors: E Canyilmaz, GDH Uslu, F Colak, B Hazeral, etal.
๐ Summary:
This study compared hippocampal dose distributions between two radiotherapy techniques โ Linac-based Intensity-Modulated Radiation Therapy (IMRT) and Volumetric Modulated Arc Therapy (VMAT) โ in high-grade glioma patients. Results showed that VMAT provided better hippocampal sparing while maintaining effective tumor coverage.
๐ฏ Research Focus: Hippocampal dose reduction, neurocognitive preservation, glioma treatment planning.
2. Dosimetric evaluation of different radiotherapy techniques in mastectomized left-sided breast cancer
๐ Citation Count: 1
๐
Year: 2023
๐ Journal: Journal of Cancer Research and Therapeutics
๐ฉโโ๏ธ Authors: N Olacak, YZ Hazeral, B Hazeral, O Duran, etal.
๐ Summary:
This paper assessed and compared multiple radiotherapy modalities (3DCRT, IMRT, VMAT) in post-mastectomy left-sided breast cancer, focusing on cardiac and pulmonary sparing. VMAT demonstrated superior organ-at-risk sparing with acceptable target coverage.
๐ฏ Research Focus: Cardiac dose sparing, breast cancer radiotherapy, left-sided irradiation safety.
3. Dosimetric Evaluation of Different Radiation Therapy Techniques in Left-Sided Breast Cancer
๐ Citation Count: 1
๐
Year: 2016
๐ Journal: International Journal of Radiation Oncology, Biology, Physics
๐ฉโโ๏ธ Authors: A Haydaroglu, YZ Hazeral, B Hazeral, etal.
๐ Summary:
This study compares 3DCRT and IMRT for left-sided breast cancer in terms of organ-at-risk exposure. Findings indicate IMRT provides improved dose conformity with reduced cardiac doses, suggesting its potential clinical advantages.
๐ฏ Research Focus: Radiation dose conformity, cardiac protection in breast radiotherapy.
4. Comparison of exposure levels of carotid artery in T1-2 glottic cancer patients undergoing radiotherapy with different modalities: A simulation-based dosimetric study
๐ Citation Count: 1
๐
Year: 2016
๐ Journal: Future Journal
๐ฉโโ๏ธ Authors: GH Uslu, E Canyilmaz, F Colak, B Hazeral, etal.
๐ Summary:
The study evaluates carotid artery dose exposure in early-stage glottic cancer patients treated with various radiotherapy techniques. IMRT was shown to significantly reduce carotid dose compared to 2D or conventional 3D approaches.
๐ฏ Research Focus: Carotid sparing, glottic cancer radiotherapy, vascular protection.
5. Dosimetric evaluation of adaptive radiotherapy in the treatment of head and neck cancer
๐
Year: 2025
๐ Journal: Medical Dosimetry
๐ฉโโ๏ธ Authors: B Hazeral, YZ Hazeral, CC Ebruli, V Semiz, M Esassolak
๐ Summary:
This study investigates adaptive radiotherapy in head and neck cancer treatment. It highlights how anatomical changes during treatment affect dosimetry and demonstrates that adaptive planning improves target coverage and spares critical organs over time.
๐ฏ Research Focus: Adaptive planning, anatomical changes, precision in radiotherapy.
6. The measurement of entrance and exit doses with in-vivo dosimetry in head and neck cancers and comparison with treatment planning doses
๐
Year: 2012
๐ Journal: Turkish Journal of Oncology
๐ฉโโ๏ธ Authors: BAA Burรงin PAฤฐDAR, Emin TAVLAYAN, Nezehat OLACAK, Mustafa ESASSOLAK
๐ Summary:
This paper measures real-time entrance and exit radiation doses in head and neck cancer patients using in-vivo dosimetry. It compares these with treatment planning system predictions and shows minor deviations, validating planning system accuracy.
๐ฏ Research Focus: In-vivo dosimetry, quality assurance, radiotherapy verification.
Conclusion
Dr. Burรงin Hazeral exemplifies the values of a Best Researcher Award recipient through her innovative, clinically relevant, and patient-focused research. Her ability to translate complex physics into tangible improvements in oncology care, coupled with her academic rigor and collaborative ethos, positions her as a leading medical physicist in Turkey and a rising figure on the global stage. Honoring her would not only celebrate her achievements but also inspire continued excellence in applied cancer research. ๐